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Background: Understanding of depression among Vietnamese people living with HIV (PLWH) is limited. This
longitudinal study examines changes in depressive symptoms and identifies its correlates among people living
with HIV under antiretroviral therapy at An Hoa Clinic.
Methods: People living with HIV ≥18 years and undergoing antiretroviral therapy for ≥3 months were eligible.
Those at final AIDS stage, too ill, or illiterate were excluded due to their inability to complete the self-administered
questionnaire. One researcher was present in the clinic for a month inviting PLWH to participate. Data were collected
from 242 PLWH at baseline (T1) and 234 after three months (T2). Depressive symptoms was measured by the Center
for Epidemiologic Studies Depression Scale (CESD). Social relationship was measured using questions created by
World Health Organization. Generalized Estimating Equations were used examining changes in depressive symptoms
with CESD cut-off <16/≥16 (mild depression) and cut-off <23/≥23 (major depression).
Results: Model 1 (CESD cut-off <16/≥16) showed that participants were not more likely to have depressive symptoms
at T2 compared to T1 (OR = 1.15, p > 0.05). Those with a co-morbidity were more likely to have depressive symptoms
than those without a co-morbidity (OR = 1.76, p < 0.05). Those with higher social relationship scores were less likely to
have depressive symptoms than those with lower scores (OR = 0.76, p < 0.001). Model 2 (CESD cut-off <23/≥23)
showed that participants were more likely to have major depressive symptoms at T2 compared to T1 (OR = 1.6,
p < 0.01) and those with higher social relationship score were less likely to have major depressive symptoms
than those with lower scores (OR = 0.73, p < 0.001).
Conclusions: People living with HIV were not more likely to have depressive symptoms (<16/≥16) but were
more likely to have major depressive symptoms (<23/≥23) at T2 vs. T1. Social relationship was found to be strongly
associated with depressive symptoms. Associations between age, individual income status, and co-morbidity with
depressive symptoms were not decisive. Gender, ethnicity, education, religion, marriage, household economy, and
adherence were not correlates.
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Depression is one of the most common mental health
diagnoses among people living with HIV/AIDS (PLWH)
[1]. The lifetime prevalence of depression among PLWH
was estimated between 22% - 45% [2]. The 12-month
prevalence of major depression was 22% in a nationally
representative cohort of PLWH receiving care in the
U.S. [3]. Although the rate among PLWH may or may
not be different from other adults in the same community,
it seemed to be lower for the general population [1, 4, 5].
The prevalence rate for major depression was 6.6% among
adults participating in a U.S. representative household
survey [6].
Studies on changes in depressive symptoms found
mixed results. Although one study found that the mood
was stable regardless of illness progression [7], another
study showed that depression decreased over a two-year
period after receiving ART [8]. Others showed that de-
pression did not change until the period of 12–18
months before AIDS diagnosis when depression started
increasing significantly [9–11].
Depression was found to be associated with HIV pro-
gression and mortality among PLWH [12–15]. In
addition, PLWH with depression were more likely to
have poor medication adherence [16–19]. Those with
depression and poor adherence had a mortality risk of
six times higher than those without depression [20]. Ef-
fective treatment of depression also improved adherence
to antiretroviral therapy (ART) [21]. Other correlates of
depression included age, gender, substance abuse, per-
ceptions of HIV related stigma, social support and social
isolation [1, 22–27].
Vietnam is a Southeast Asian country with over 90
million people. It is estimated that 197,335 people were
living with HIV/AIDS in 2011 and 263,317 in 2015 [28].
Because HIV is usually linked to drug use and commer-
cial sex workers [29, 30], which are illegal and culturally
unacceptable in Vietnam, PLWH are likely to experi-
ence mental health problems, particularly depression, due
to stigma and discrimination [31]. Social support and ac-
cess to mental health care for PLWH are also insufficient
in Vietnam [32–34].
Understanding about depression among PLWH in
Vietnam is limited. In our literature review, we found
only two cross-sectional studies on depression among
PLWH in Vietnam. One showed that depression preva-
lence among HIV-infected men over a month was
18.7%, which seems to be much higher than the general
population of Vietnamese men [35]. The second article
found an inverse association between ART adherence
and depression [36].
This study, therefore, aims to address this gap by (1)
examining changes in depression symptoms among
PLWH at An Hoa clinic in Ho Chi Minh city (HCMc),Vietnam; and (2) identifying correlates of depression.
Findings from this study will improve knowledge about
depression among PLWH in Vietnam and help design
effective interventions.
Methods
Study design and population
This longitudinal study was conducted from November
2012 to April 2013 at An Hoa Clinic of Center for Pre-
ventive Medicine in District 6, HCMC, Vietnam. PLWH
who were 18 years or older; undergoing ART for
≥3 months; and agreed to participate were eligible. Those
at final AIDS stage, too ill, or illiterate were excluded due
to their inability to complete the self-administered
questionnaire.
One researcher stayed at the clinic during operating
hours for one month and approached PLWH who visited
the clinic for services, in order to screen them for eligi-
bility and invite them to participate in the study. PLWH
were given information about the study and written
consent forms were collected if they agreed to partici-
pate. During the month, the researcher approached 255
of 1260 PLWH registered in the clinic. Of these partici-
pants, two were illiterate, one was at end stage of AIDS;
and two were not receiving ART. Of 250 PLWH who
agreed to participate, two subsequently died, four were
incarcerated, and two later withdrew at the first admin-
istration. Therefore, the final sample size at baseline
was 242. Because our resources were limited and two
previous studies showed a period of three month
follow-up appropriate to see changes in depressive
symptoms [37, 38], data were collected at baseline (T1)
and after three months (T2) from T1. The study was
approved by the Research Ethics Committee, University
of Medicine and Pharmacy, Ho Chi Minh City and the
Clinic Administrative Board.
Measurement
Self-administered questionnaires were provided to the
participants when they visited the clinic. Record review
and pill counts were used along with self-reports to
determine adherence.
Dependent variable
Depression was measured by the Center for Epidemiologic
Studies Depression Scale (CESD). CESD was created in
1977 and widely used to measure depression in com-
munities [39, 40]. Particularly, it was validated among
Vietnamese [40]. CESD measures nine domains of de-
pression defined by the American Psychiatric Associ-
ation [41] including Sadness, Loss of interest, Appetite,
Sleep, Thinking/concentration, Guilt, Tired, Movement,
and Suicidal ideation. It is comprised of 20 items, each
of which is rated as 0 = “Rarely or none of the time
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“Occasionally or a moderate amount of time (3–4 days)”, and
3 = “Most or all of the time (5–7 days)”. Four positive items
have the scores reversed. As such, the total score ranges from
0 to 60. Two categorical variables were created as “possible de-
pression” or “mild depressive symptoms” where the cut-off
point is ≥/<16; and “probable depression” or “major depres-
sion” where the cut-off point is ≥/<23 [39]. However, we
only used the terms “mild depression” and “major de-
pression” for consistency. Cronbach’s alpha for T1
and T2 were 0.87 and 0.89 which showed strong in-
ternal consistency reliability.
Independent variables
Social relationships among PLWH
Social Relationships Were measured by four questions
created by the World Health Organization (WHO-QOL
BREF) [42]. The first one is: “To what extent do you feel
accepted by the people you know?” and five responses
are “Not at all”, “A little”, “Moderately”, “Mostly”, and
“Completely”. The other three are “How satisfied are you
with your personal relationships?”, “How satisfied are you
with your sex life?”, and “How satisfied are you with the
support you get from your friends?” and the responses are
“Very dissatisfied”, “Dissatisfied”, “Neither satisfied nor
dissatisfied”, “Satisfied”, and “Very satisfied”. The score for
each question is from one (negative) to five (positive). The
total score, therefore, ranges from 4 to 20. Cronbach’s
alpha for T1 and T2 were 0.66 and 0.76 which showed
good internal consistency reliability.
Medication adherence
A definition of medication adherence by the Vietnam
Ministry of Health was modified to measure adherence
[43]. First, two yes-no questions were asked: (i) “During
the last month, have you ever given your medication to
others?”; and (ii) “During the last month, have you ever
forgotten to take your medication?” Second, although
self-reports of adherence are fairly accurate [44],
returned pills were counted to cross-validate. A mismatch
between self-reports and pill counts resulted in an answer
of “Yes” for the question (ii). Third, the appointment date
was checked to see whether the participant was late, i.e.,
did not re-visit the clinic at the appointed date or within
the following day. An answer of “Yes” to any of these re-
sulted in coding of poor adherence.
Other independent variables including co-morbidity,
age, gender, ethnicity, education, marital status, religion,
individual income status, and household economy were
self-reported. Co-morbidity was “Yes” if a respondent
had at least one of these diseases including tuberculosis,
hepatitis B or C, cardiovascular disease, or kidney diseases.
Age groups were “18-30 years”, “31-40 years”, and “41-59years”. Gender was “Female” or “Male”. Ethnicity was
“Kinh people” (main ethnic group in Vietnam) or
“Others”. Participants’ levels of education were grouped
into “Below Grade 10” or “≥Grade 10”. Responses for
marital status were grouped into “Living with a spouse/
partner” or “Others”. Responses for having a religion were
“Yes” or “No”. Individual income status was responded as
“Regular”, “Irregular”, or “No income”. Household econ-
omy was categorized as “Economically disadvantaged” or
“Not economically disadvantaged”.
Data analysis
Data were entered using Epidata 3.1 software. Analyses
were performed with the use of SAS software, v9.4. Fre-
quencies and percentages were generated for categorical
variables. Means and standard deviations were generated
for continuous variables. Chi-square test was used to see
whether there were differences in demographic charac-
teristics of the samples at two time points. Two models
with CESD cut-off of 16 “mild depression” (model 1)
and 23 “major depression” (model 2) were run. Although
the first cut-off (<16/≥16) was traditional and used in
most research with CES-D, the second cut-off (<23/≥23)
was also used because somatic depressive symptoms on
CES-D can overlap with HIV-related disease symptoms
(e.g., poor appetite) and inflate CES-D scores [45]. Po-
tential correlates were included in these two models and
odd ratios were reported for each correlates. Tukey-
Kramer adjustment was applied when conducting mul-
tiple comparison for two variables: age and individual
income status. All p-values are two tailed and p-values
of <0.05 were considered statistically significant.
Generalized Estimating Equations (GEE) were used to
examine changes in depressive symptoms. GEE is a sug-
gested method to analyze correlated longitudinal data
[46]. It provides consistent and robust estimation of pa-
rameters’ standard errors and can be applied to different
types of outcome variables (e.g., continuous, dichotomous,
and count). GEE can account for unequal intervals among
waves and for missing data in longitudinal studies.
Results
Characteristics of the sample
At baseline, the average age of participants was 33 years,
ranging from 18 to 59 years; about 62% were from 31–40
years (Table 1). Female made up 26.86% of the sample. A
majority were “Kinh people” (85.54%); did not go to senior
high school (78.10%); and had a religion (88.43%). About
half were living with a spouse (52.89%); and had a co-
morbidity (51.65%). A quarter (24.79%) had no income.
Over one-third (40.08%) lived in economically disadvan-
taged household. About 70.66% adhered to treatment.
The mean of the social relationship score was 12.33. Of
242 participants, 61.98% (150 participants) had depression
Table 1 Characteristics of the samples
T1 (n = 242) T2 (n = 234)
N Mean (SD) or % N Mean (SD) or %
Age
18–30 67 27.69% 67 28.63%
31–40 151 62.40% 143 61.11%
41-59 24 9.92% 24 10.26%
Gender (Female) 65 26.86% 64 27.35%
Ethnicity (Kinh people) 207 85.54% 200 85.47%
Education (Below Grade 10) 189 78.10% 183 78.21%
Religion (Yes) 214 88.43% 209 89.32%
Marital status (Live with spouse) 128 52.89% 123 52.56%
Individual income status
Regular 106 43.80% 108 46.15%
Irregular 76 31.40% 69 29.49%
No income 60 24.79% 57 24.36%
Household economy (economically disadvantaged) 97 40.08% 86 36.75%
Co-morbidity (Yes) 125 51.65% 125 53.42%
Adherence (Yes) 171 70.66% 194 82.91%
Social relationship score 242 12.33 (2.78) 234 12.33 (2.91)
CESD mean score (SD) 242 19.91 (10.33) 234 20.56 (10.23)
CESD cut-off (≥16)
Yes 150 61.98% 148 63.25%
No 92 38.02% 86 36.75%
CESD cut-off (≥23)
Yes 84 34.71% 99 42.31%
No 158 65.29% 135 57.69%
CESD the Center for Epidemiologic Studies Depression scale
SD Standard Deviation
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mean score was 19.91.
The number of participants at T1and T2 was, respect-
ively, 242 and 234. Chi-square test showed that differences
in demographic characteristics at the two time points were
not significant (p = 0.904 for gender, p = 0.959 for age
groups, p = 0.983 for ethnicity, p = 0.978 for education
level, and p = 0.759 for religion).
Changes in depressive symptoms and correlates
Model 1 with CESD cut-off of 16 showed that participants
were not more likely to have depressive symptoms at T2
compared to T1 (OR = 1.15, p > 0.05). Model 2 with CESD
cut-off of 23 showed that odds of having major depression
at T2 compared to T1 was 1.6 (p < 0.01) (Table 2).
Model 1 found two correlates with depression, co-
morbidity and social relationship. Those with a co-
morbidity were more likely to have depressive symptoms
than those without a co-morbidity (OR = 1.76, p < 0.05).
Those with higher social relationship score were lesslikely to have depressive symptoms than those with
lower scores (OR = 0.76, p < 0.001). Model 2 found that
only social relationship was associated with depression.
Those with higher social relationship score were less
likely to have major depression than those with lower
scores (OR = 0.73, p < 0.001). In both models, depression
was not significantly associated with other variables such
as age, gender, and medication adherence (p > 0.05).
Discussion
The findings showed that PLWH were not more likely
to have depressive symptoms (CESD ≥ 16) at T2 com-
pared to baseline (model 1) but were more likely to have
major depression (CESD ≥ 23) at T2 compared to base-
line (model 2). This may suggest that progression from
not having depression (CESD < 16) to having depression
was not as significant as the progression from having
mild to major depression. One possible explanation may
be because those who already had mild depression were
more likely to live in an unfavorable environment where
Table 2 GEE for binomial models with CESD cut-off of 16 and 23
Model 1 - CESD (<16/≥16) Model 2 - CESD (<23/≥23)
OR 95% CI OR 95% CI
Time 2 vs. Time 1 1.15 (0.86, 1.53) 1.60 (1.13, 2.24)**
Age
(18–30) vs. (31–40) 0.87 (0.43, 1.72) 0.63 (0.32, 1.24)
(18–30) vs. (41–59) 0.72 (0.24, 2.22) 0.38 (0.14, 1.06)
(31–40) vs. (41–59) 0.83 (0.30, 2.33) 0.60 (0.28, 1.30)
Female vs. Male 1.06 (0.60, 1.88) 1.21 (0.70, 2.11)
Kinh people vs. others 0.72 (0.33, 1.54) 0.69 (0.38, 1.28)
Below vs. Above grade 10 1.32 (0.76, 2.26) 1.11 (0.62, 1.99)
Religion (Yes vs. No) 0.80 (0.38, 1.69) 1.01 (0.46, 2.19)
Live with spouse vs. not 1.02 (0.64, 1.64) 1.10 (0.69, 1.75)
Individual income status
Regular vs. irregular 1.08 (0.58, 2.04) 0.63 (0.34, 1.20)
Regular vs. no income 0.84 (0.41, 1.72) 0.57 (0.29, 1.10)
Irregular vs. no income 0.78 (0.35, 1.72) 0.89 (0.46, 1.72)
Household economy (Not economically disadvantaged vs. disadvantaged) 0.69 (0.45, 1.04) 0.90 (0.55, 1.48)
Co-morbidity (Yes vs. No) 1.76 (1.15, 2.70)* 1.23 (0.77, 1.98)
Social relationship (one unit difference) 0.76 (0.69, 0.82)*** 0.73 (0.66, 0.81)***
Adherence (Yes vs. No) 0.73 (0.47, 1.16) 0.69 (0.44, 1.09)
Note: the models included all covariates
Probability of having depression was modeled *p < 0.05;**p < 0.01; ***p < 0.001
OR odds ratio, CESD the Center for Epidemiologic Studies Depression scale, GEE Generalized Estimating Equations
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support were more popular than those without depression
(i.e., CESD < 16). As environmental effects accumulated,
depression symptoms increased. However, this is specula-
tive since data on environment, especially social environ-
ment, were not collected. In addition, although it is
possible that the effect of previous exposure to the ques-
tionnaire may influence responses at T2 (e.g., PLWH
responded with more depression at T2 expecting to
receive more support), it may not be plausible because dif-
ferences in depression was not significant in model 1.
Although reliable population comparisons are not avail-
able, high prevalence of major depression (34.31%) in the
study sample likely indicates that interventions are needed
to prevent and control depression among PLWH.
Despite that women were found more likely than men
to suffer depression in the general population [47], the
association was less consistent among PLWH [1, 48–50].
In this study, women seemed to have more depression
although the association was insignificant. It is worth
noting that women made up only 26% of the sample,
and so the statistical power to detect differences between
the sexes may be limited.
Medication adherence was not associated with depres-
sion in this study. This is not consistent with other studies
which found that depression was associated with pooreradherence [16, 17, 36]. This may be due to PLWH’s re-
activity, i.e., trying to improve adherence, as they may
think that they were under a close supervision when par-
ticipating in the study. However, it is also worth noting
that this study used a stricter definition of adherence by
which remembering to take medication was not the only
criterion. PLWH needed to revisit the clinic on the
appointment date or the next day at the latest. As such,
the finding may not be comparable to other studies.
Having a co-morbidity seems to be associated with
greater likelihood of depression. Although the associ-
ation was only significant in model 1 (CESD <16/≥16),
the direction of the effect was the same in model 2
(ORs > 1). The effect of co-morbidity on depression is
plausible due to the impact of deteriorating physical and
mental health and the stress of cost and side-effects
related to treatment medication for co-morbidities.
Although depression can be effectively treated among
PLWH [51, 52], interventions should focus not only on
treating depression but also treating other co-
morbidities. In addition, the finding that social relation-
ship was the strongest correlate with depression in this
study emphasized the importance of addressing psycho-
social needs of PLWH. Improving social relationship
should be included as an essential strategy in future
interventions.
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validated measurement tools, and had an adequate sam-
ple size, it has some limitations. First, this study was
conducted in only one clinic so generalizability was
limited. Second, depression were self-reported so they
may not be as accurate as clinical diagnosis. However,
as the same self-reported tool was used at both T1 and
T2, the effect of this bias would be limited. Third,
although the instruments were validated, recall bias is
possible in self-reported data. Fourth, as depression
treatment was not controlled for, it is possible that
some received depression treatment elsewhere during
the three-month study period. However, the chance
was minimal because depression care was very limited
in Vietnam [34]. Mental health services, even in big
cities such as Hanoi and Ho Chi Minh city, do not
focus on depression but mainly on schizophrenia, bipo-
lar disorder, and epilepsy [34]. Finally, since this is an
observational study without a comparison group, many
factors which could affect depression could not be fully
controlled.
Conclusion
PLWH were not more likely to have depression (<16/≥16)
at T2 compared with baseline but more likely to have
major depression (<23/≥23) at T2 compared with baseline.
Social relationship was found to be strongly associated
with depression. Associations between age, individual in-
come status, and co-morbidity were not decisive. Gender,
ethnicity, education, religion, marriage, household
economy, and adherence were not correlates.
Our study was a response to a call for more studies on
HIV and depression in Asian countries [53]. It contrib-
utes to understanding of depression among PLWH re-
ceiving ART in Asia, and particularly in Vietnam. Our
findings emphasize the need for interventions addressing
mental health among PLWH in Vietnam. This study can
be useful in designing and building effective interven-
tions to prevent and control depression. Future research
should include larger and more diverse samples to in-
crease generalizability; control effects associated with
other factors such as previous exposure to the question-
naire; improve depression diagnosis by clinical assess-
ment; and evaluate severity of co-morbidities to increase
the strength of conclusions.
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